Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0022 | 0.0523 | 0.0336 |
Leishmania major | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1111 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.0523 | 0.1111 |
Echinococcus multilocularis | dna polymerase eta | 0.0022 | 0.0523 | 0.1111 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.0523 | 0.1111 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0019 | 0.0313 | 0.0186 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0022 | 0.0523 | 0.1111 |
Toxoplasma gondii | thioredoxin reductase | 0.0054 | 0.254 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0022 | 0.0523 | 0.1111 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0019 | 0.0313 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1111 |
Leishmania major | trypanothione reductase | 0.0054 | 0.254 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0019 | 0.0313 | 0.0186 |
Leishmania major | DNA polymerase eta, putative | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0022 | 0.0523 | 0.1763 |
Mycobacterium tuberculosis | Probable reductase | 0.0123 | 0.6906 | 0.8844 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0123 | 0.6906 | 0.8844 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0019 | 0.0313 | 0.0186 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0019 | 0.0313 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0137 | 0.7773 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0054 | 0.254 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0054 | 0.254 | 0.3025 |
Plasmodium falciparum | thioredoxin reductase | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0019 | 0.0313 | 0.0186 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0019 | 0.0313 | 0.0043 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0022 | 0.0523 | 0.0259 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0022 | 0.0523 | 0.206 |
Echinococcus multilocularis | dna polymerase kappa | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1111 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0054 | 0.254 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Brugia malayi | isocitrate dehydrogenase | 0.0018 | 0.0271 | 0.1068 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.0523 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0123 | 0.6906 | 0.8844 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Giardia lamblia | DINP protein human, muc B family | 0.0022 | 0.0523 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0019 | 0.0313 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0054 | 0.254 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0054 | 0.254 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0019 | 0.0313 | 0.0906 |
Schistosoma mansoni | DNA polymerase eta | 0.0022 | 0.0523 | 0.0259 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0019 | 0.0313 | 0.0906 |
Echinococcus granulosus | dna polymerase eta | 0.0022 | 0.0523 | 0.1111 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0123 | 0.6906 | 0.8844 |
Loa Loa (eye worm) | glutathione reductase | 0.0054 | 0.254 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0019 | 0.0313 | 0.0186 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0019 | 0.0313 | 0.0186 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0054 | 0.254 | 1 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0022 | 0.0523 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0022 | 0.0523 | 0.1111 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0022 | 0.0523 | 0.0336 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0137 | 0.7773 | 1 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0019 | 0.0313 | 0.0186 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0123 | 0.6906 | 0.8844 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0019 | 0.0313 | 0.0906 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0137 | 0.7773 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0523 | 0.1763 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0019 | 0.0313 | 0.0906 |
Trypanosoma brucei | trypanothione reductase | 0.0054 | 0.254 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0019 | 0.0313 | 0.0056 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0022 | 0.0523 | 0.206 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0123 | 0.6906 | 0.8844 |
Treponema pallidum | NADH oxidase | 0.0019 | 0.0313 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0137 | 0.7773 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Brugia malayi | Isocitrate dehydrogenase | 0.0018 | 0.0271 | 0.1068 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0022 | 0.0523 | 1 |
Trypanosoma brucei | unspecified product | 0.0022 | 0.0523 | 0.1763 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0019 | 0.0313 | 0.1234 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.0523 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0018 | 0.0271 | 0.0733 |
Plasmodium falciparum | thioredoxin reductase | 0.0054 | 0.254 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0022 | 0.0523 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0523 | 0.1763 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1763 |
Plasmodium vivax | glutathione reductase, putative | 0.0054 | 0.254 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0019 | 0.0313 | 0.0186 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.0523 | 0.1111 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.0523 | 0.1763 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0054 | 0.254 | 1 |
Brugia malayi | glutathione reductase | 0.0054 | 0.254 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0022 | 0.0523 | 0.0259 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0.0271 | 0.0733 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0054 | 0.254 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.